CYPH
CYPH
NASDAQ · Biotechnology

Cypherpunk Technologies Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.19
+0.13 (+12.26%)
As of May 16, 2:22 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +3,153.8% upside
Low Target $25.17
Average Target $38.72
High Target $55.57
Current Price $1.19
Current
$1.19
Target
$38.72
$25.17 $38.72 avg $55.57
Scenario Analysis
Bear Case
$25.17
2,015.1%
Low target
Base Case
$38.72
+3,153.8%
Avg target
Bull Case
$55.57
+4,569.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.70
-67.8% from high
52-Week Low
$0.23
+412.9% from low
Target vs 52W High
$38.72
+946.5% vs high
Next Earnings Report
May 18, 2026
Today
EPS Est: $-0.12
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%